Attention deficit and hyperactivity disorder: a therapeutic option.

Area of Science:

• Pharmacology
• Neuroscience
• Clinical Psychology

Background:

• Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder.
• Standard treatments for ADHD include psychostimulant medications.
• Some patients do not respond well to or tolerate psychostimulants, necessitating alternative therapies.

Purpose of the Study:

• To evaluate a specific therapeutic regimen for treating patients diagnosed with ADHD.
• To assess the efficacy of a non-psychostimulant treatment approach.

Main Methods:

• A cohort of 140 patients diagnosed with ADHD was enrolled.
• Comprehensive physical, neurological, and laboratory evaluations were conducted.
• Treatment involved a compounded product containing a tricyclic antidepressant and an anxiolytic.

Main Results:

• The therapeutic regimen demonstrated positive results in 71.43% of the patients.
• Significant improvements were observed in controlling hyperactivity.
• Enhanced dispersion and attention deficit control were noted.

Conclusions:

• The evaluated therapeutic regimen is an effective alternative treatment for ADHD.
• This approach is particularly beneficial for patients who do not adapt to psychostimulant drugs.
• Further research into non-psychostimulant ADHD treatments is warranted.